×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Advances in Oncology Extend Lives, but Lead to New Safety Considerations for Sponsors and Investigators

From cardiovascular adverse events to complex dosing regimens, oncology trials present unique safety-related considerations. Left unaddressed, they could undermine a trial or put patient safety at risk. In this paper, we discuss some of those issues and how sponsors can best address them.

Previous Video
AIMS 4.1 Promo
AIMS 4.1 Promo

Custom-built to streamline the adjudication process, the AIMS platform allows for enhanced endpoint adjudic...

Next Video
Safety Reporting Reference Model: Optimizing Global Safety Reporting in Clinical Trials using Local Laws
Safety Reporting Reference Model: Optimizing Global Safety Reporting in Clinical Trials using Local Laws

New Blog: "Ask the IRB Experts"

Visit Blog